Insilico Medicine Hong Kong Limited
Clinical trials sponsored by Insilico Medicine Hong Kong Limited, explained in plain language.
-
New hope for advanced cancer: first human trial of ISM5939 begins
Disease control Not yet recruitingThis study tests a new drug called ISM5939 in people with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects. About 159 adults will take part in three phases: first, finding the rig…
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
New drug ISM8969 put to the test in first human safety trial
Knowledge-focused Not yet recruitingThis early-stage study tests the safety and tolerability of a new oral drug called ISM8969 in about 100 people. Participants include healthy adults, elderly individuals, and obese adults at risk for heart disease. The goal is to see if the drug is safe and how the body processes …
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:09 UTC